Bo Kruse

Director of Finance/CFO at Y-MABS THERAPEUTICS, INC.

Net worth: 3 M $ as of 2024-03-30

52 year

43 connections

Health Technology

Consumer Services

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Thomas Gad	M	54	Y-MABS THERAPEUTICS, INC.	9 years
James Healy	M	58	Y-MABS THERAPEUTICS, INC.	7 years
Michael Rossi	M	53	Y-MABS THERAPEUTICS, INC.	1 years
David Gill	M	69	Y-MABS THERAPEUTICS, INC.	7 years
Johan Ernst Wedell-Wedellsborg	M	54	Y-MABS THERAPEUTICS, INC.	9 years
Ashutosh Tyagi	M	47	Y-MABS THERAPEUTICS, INC.	7 years
Gérard Ber	M	66	Y-MABS THERAPEUTICS, INC.	6 years
Anthony Pagano	M	46	GENMAB A/S	17 years
Martine van Vugt	M	71	GENMAB A/S	23 years
Laura Hamill	F	60	Y-MABS THERAPEUTICS, INC.	4 years
Anders Gersel Pedersen	M	73	GENMAB A/S	21 years
Torben Lund-Hansen	M	73	Y-MABS THERAPEUTICS, INC.	8 years
Birgitte Stephensen	F	63	GENMAB A/S	22 years
Joris Wilms	M	50	Y-MABS THERAPEUTICS, INC.	7 years
Vignesh Rajah	M	59	Y-MABS THERAPEUTICS, INC.	4 years
Sue Smith	F	54	Y-MABS THERAPEUTICS, INC.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Claus Juan Møller-San Pedro	M	62	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. Y-MABS THERAPEUTICS, INC. GENMAB A/S	28 years
Michael Blair Widmer	M	76	GENMAB A/S	11 years
Michael Buschle	M	64	Y-MABS THERAPEUTICS, INC.	1 years
Christina Hahner	F	-	GENMAB A/S	-
Daniel John Bruno	M	45	GENMAB A/S	5 years
Michael K. Bauer	M	60	GENMAB A/S	14 years
Burt Malkiel	M	90	GENMAB A/S	11 years
Nedjad Losic	M	54	GENMAB A/S	-
Tom Vink	M	61	GENMAB A/S	-
Steen Lisby	M	60	Y-MABS THERAPEUTICS, INC. GENMAB A/S	16 years
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 years
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 years
Jorgen Petersen	M	-	GENMAB A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 years
Philip Herman	M	-	Y-MABS THERAPEUTICS, INC.	3 years
Patrick van Berkel	M	55	GENMAB A/S	9 years
Irwin Lerner	M	93	GENMAB A/S	-
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 years
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 years
Paul W. H. I. Parren	M	60	GENMAB A/S	16 years
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 years
Joseph Fred Yospe	M	66	GENMAB A/S	2 years
Michael Wolff Jensen	M	53	GENMAB A/S	3 years
Greg Raskin	M	51	Y-MABS THERAPEUTICS, INC.	5 years
Eva Ehrnrooth	M	57	GENMAB A/S	2 years

Statistics

Country	Connections	% of total
Denmark	28	65.12%
United States	17	39.53%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections

Stock Market
Insiders
Bo Kruse
Personal Network